A/HRC/22/53
Contents
Page
I.
Introduction .............................................................................................................
1–2
3
II.
Activities of the Special Rapporteur .......................................................................
3–10
3
III.
IV.
V.
2
Paragraphs
A.
Upcoming country visits and pending requests ..............................................
3–4
3
B.
Highlights of key presentations and consultations ..........................................
5–10
3
Applying the torture and ill-treatment protection framework
in health-care settings ..............................................................................................
11–38
4
A.
Evolving interpretation of the definition of torture and ill-treatment .............
14–16
4
B.
Applicability of the torture and ill-treatment framework
in health-care settings .....................................................................................
17–26
5
C.
Interpretative and guiding principles ..............................................................
27–38
6
Emerging recognition of different forms of abuses in health-care settings .............
39–80
9
A.
Compulsory detention for medical conditions ................................................
40–44
9
B.
Reproductive rights violations ........................................................................
45–50
10
C.
Denial of pain treatment .................................................................................
51–56
12
D.
Persons with psychosocial disabilities ............................................................
57–70
13
E.
Marginalized groups .......................................................................................
71–80
17
Conclusions and recommendations .........................................................................
81–90
20
A.
Significance of categorizing abuses in health-care settings as torture
and ill-treatment ..............................................................................................
81–84
20
B.
Recommendations...........................................................................................
85–90
21